Phase I/II trials of preventive HIV vaccine candidates. Dose and schedule: summary.
Gorse
G J
GJ
Department of Internal Medicine, Saint Louis University Health Sciences Center, Missouri 63110-0250.
D016915:AIDS Vaccines / Q000008:administration & dosage*; D000818:Animals; D002985:Clinical Protocols; D017321:Clinical Trials, Phase I as Topic; D017322:Clinical Trials, Phase II as Topic; D004306:Dose-Response Relationship, Immunologic; D015483:HIV Antibodies / Q000096:biosynthesis; D015658:HIV Infections / Q000517:prevention & control*; D006801:Humans; D007115:Immunization Schedule; D008213:Lymphocyte Activation; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology
D016915:AIDS Vaccines; D015483:HIV Antibodies